An activated Rac mutant functions as a dominant negative for membrane ruffling.
Previous studies have shown that point mutations in the effector domain of Rac1 block specific downstream pathways such as PAK, JNK/SAPK kinases and membrane ruffling. Specifically, the F37A mutation, made in a constitutively activated Q61L background, activates PAK but fails to induce membrane ruffles. We now show that Q61L/F37A Rac not only fails to induce ruffling but potently blocks membrane ruffling induced by serum or PDGF. In the presence of serum, cells do extend filopodia, suggesting that this mutant only blocks a subset of the effectors that induce cytoskeletal reorganization. At later times, this rac mutant induces membrane blebbing, but not apoptosis. These results show that Q61L/F37A Rac, is constitutively activated with respect to PAK activation but functions as a dominant negative for another pathway, membrane ruffling. That an effector domain point mutant can simultaneously function as a dominant negative and dominant positive for different pathways implies that effects of these variants on cell functions must be interpreted with caution.
Department of Vascular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
M A
MA
Schwartz
J E
JE
Meredith
W B
WB
Kiosses
D016475:3T3 Cells; D000818:Animals; D002455:Cell Division; D019204:GTP-Binding Proteins / Q000235:genetics* / Q000502:physiology*; D051379:Mice; D016296:Mutagenesis; D020744:rac GTP-Binding Proteins
D019204:GTP-Binding Proteins; D020744:rac GTP-Binding Proteins